{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:50:02Z","timestamp":1791903002935,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1007\/bf02821934","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T10:17:48Z","timestamp":1201342668000},"page":"154-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Homing behaviour of the malignant cell clone in multiple myeloma"],"prefix":"10.1007","volume":"15","author":[{"given":"Ivan","family":"Van Riet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Vanderkerken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"de Greef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Van Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1998,9,1]]},"reference":[{"key":"BF02821934_CR1","first-page":"2","volume":"34","author":"MA Duchosal","year":"1997","unstructured":"Duchosal MA. B-cell development and differentiation.Semin Hematol 1997;34: 2\u201312.","journal-title":"Semin Hematol"},{"key":"BF02821934_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3109\/10428199309145751","volume":"9","author":"I Van Riet","year":"1993","unstructured":"Van Riet I, Van Camp B. The involvement of adhesion molecules in the biology of multiple myeloma.Leuk Lymph 1993;9: 441\u2013452.","journal-title":"Leuk Lymph"},{"key":"BF02821934_CR3","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1182\/blood.V76.10.1908.bloodjournal76101908","volume":"76","author":"FM Uckun","year":"1990","unstructured":"Uckun FM. Regulation of B cell ontogeny.Blood 1990;76: 1908\u20131923.","journal-title":"Blood"},{"key":"BF02821934_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-5699(91)90102-Y","volume":"12","author":"RB Gallagher","year":"1991","unstructured":"Gallagher RB, Osmond DG. To B or not to B: that is the question.Immunol Today 1991;12: 1\u20133.","journal-title":"Immunol Today"},{"key":"BF02821934_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-065X.1986.tb01484.x","volume":"91","author":"ICM MacLennan","year":"1986","unstructured":"MacLennan ICM, Gray D. Antigen-driven selection of virgin and memory B cells.Immunol Rev 1986;91: 61\u201385.","journal-title":"Immunol Rev"},{"key":"BF02821934_CR6","first-page":"37","volume":"159","author":"ICM MacLennan","year":"1990","unstructured":"MacLennan ICM, Lieu YJ, Oldfield S, Zhang J, Lane PJL. The evolution of B-cell clones.Curr Topics Microbiol Immunol 1990;159: 37\u201360.","journal-title":"Curr Topics Microbiol Immunol"},{"key":"BF02821934_CR7","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/eji.1830161018","volume":"16","author":"F Ho","year":"1986","unstructured":"Ho F, Lortan JE, MacLennan ICM, Khan M. Distinct short-lived and long-lived antibody producing cell populations.Eur J Immunol 1986;16: 1297\u20131301.","journal-title":"Eur J Immunol"},{"key":"BF02821934_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/302575a0","volume":"302","author":"S Tonegawa","year":"1983","unstructured":"Tonegawa S. Somatic generation of antibody diversity.Nature 1983;302: 575\u2013581.","journal-title":"Nature"},{"key":"BF02821934_CR9","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1084\/jem.170.4.1211","volume":"170","author":"T Manser","year":"1989","unstructured":"Manser T. Evolution of antibody structure during the immune response: the differentiative potential of a single B lymphocyte.J Exp Med 1989;170: 1211\u20131230.","journal-title":"J Exp Med"},{"key":"BF02821934_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/342929a0","volume":"342","author":"YJ Liu","year":"1989","unstructured":"Liu YJet al.: The mechanism of antigen-driven selection in germinal centres.Nature 1989;342: 929\u2013931.","journal-title":"Nature"},{"key":"BF02821934_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","volume":"12","author":"ICM MacLennan","year":"1994","unstructured":"MacLennan ICM. Germinal centres.Annu Rev Immunol 1994;12: 117\u2013139.","journal-title":"Annu Rev Immunol"},{"key":"BF02821934_CR12","first-page":"1","volume":"46","author":"R Benner","year":"1981","unstructured":"Benner R, Hijmans W, Haaijman JJ. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation.Clin Exp Immunol 1981;46: 1\u20138.","journal-title":"Clin Exp Immunol"},{"key":"BF02821934_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.iy.06.040188.002121","volume":"6","author":"AF Williams","year":"1988","unstructured":"Williams AF, Barclay AN. The immunoglobulin superfamily-domains for cell recognition.Annu Rev Immunol 1988;6: 381\u2013405.","journal-title":"Annu Rev Immunol"},{"key":"BF02821934_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.bi.59.070190.001321","volume":"59","author":"M Takeichi","year":"1990","unstructured":"Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion.Annu Rev Biochem 1990;59: 237\u2013252.","journal-title":"Annu Rev Biochem"},{"key":"BF02821934_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0092-8674(87)90233-9","volume":"48","author":"RO Hynes","year":"1987","unstructured":"Hynes RO. Integrins: a family of cell surface receptors.Cell 1987;48: 549\u2013554.","journal-title":"Cell"},{"key":"BF02821934_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/jcb.240450204","volume":"45","author":"LA Lasky","year":"1991","unstructured":"Lasky LA. Lectin cell adhesion molecules (LEC-CAMs): a new family of cell adhesion proteins involved with inflammation.J Cell Biochem 1991;45: 139\u2013146.","journal-title":"J Cell Biochem"},{"key":"BF02821934_CR17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/0092-8674(89)90620-X","volume":"56","author":"LM Stoolman","year":"1989","unstructured":"Stoolman LM. Adhesion molecules controlling lymphocyte migration.Cell 1989;56: 907\u2013910.","journal-title":"Cell"},{"key":"BF02821934_CR18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1182\/blood.V79.5.1185.1185","volume":"79","author":"LG Billips","year":"1992","unstructured":"Billips LGet al. Differential roles of stromal cells, interleukin-7, and ckit-ligand in the regulation of B lymphopoiesis.Blood 1992;79: 1185\u20131192.","journal-title":"Blood"},{"key":"BF02821934_CR19","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1182\/blood.V82.10.3005.3005","volume":"82","author":"LF Gibson","year":"1993","unstructured":"Gibson LF, Piktel D, Landreth KS. Insulin-like growth factor-1 potentiates expansion of interleukin-7 dependent pro-B cells.Blood 1993;82: 3005\u20133011.","journal-title":"Blood"},{"key":"BF02821934_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/368643a0","volume":"368","author":"C Hannum","year":"1994","unstructured":"Hannum Cet al. Ligand for FLT3\/FLK2 receptor kinase regulates growth of haematopoietic stem cells and is encoded by variant RNA\u2019s.Nature 1994;368: 643\u2013648.","journal-title":"Nature"},{"key":"BF02821934_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/stem.5530100104","volume":"10","author":"K Dorschkind","year":"1992","unstructured":"Dorschkind K, Landreth KS. Regulation of B cell differentiation by bone marrow stromal cells.Int J Cell Cloning 1992;10: 12\u201317.","journal-title":"Int J Cell Cloning"},{"key":"BF02821934_CR22","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1172\/JCI115403","volume":"88","author":"DH Ryan","year":"1991","unstructured":"Ryan DH, Nuccie BL, Abboud CN, Winslow JM. Vascular adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells.J Clin Invest 1991;88: 995\u20131004.","journal-title":"J Clin Invest"},{"key":"BF02821934_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev.iy.10.040192.003021","volume":"10","author":"LJ Picker","year":"1992","unstructured":"Picker LJ. Physiological and molecular mechanisms of lymphocyte homing.Annu Rev Immunol 1992;10: 561\u2013591.","journal-title":"Annu Rev Immunol"},{"key":"BF02821934_CR24","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1083\/jcb.105.2.983","volume":"105","author":"S Jalkanan","year":"1987","unstructured":"Jalkanan S, Bartgatze RF, de los Toyos J, Butcher EC. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85\u201395 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells.J Cell Biol 1987;105: 983\u2013990.","journal-title":"J Cell Biol"},{"key":"BF02821934_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-065X.1989.tb00012.x","volume":"108","author":"A Holzmann","year":"1989","unstructured":"Holzmann A, Weissman IL. Integrin molecules involved in lymphocyte homing to Peyer\u2019s patches.Immunol Rev 1989;108: 45\u201361.","journal-title":"Immunol Rev"},{"key":"BF02821934_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.4049\/jimmunol.140.3.693","volume":"140","author":"A Holzmann","year":"1988","unstructured":"Holzmann Aet al. Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing.J Immunol 1988;140: 693\u2013699.","journal-title":"J Immunol"},{"key":"BF02821934_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1084\/jem.173.6.1297","volume":"173","author":"G Koopman","year":"1991","unstructured":"Koopman Get al. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen-1\/intercellular adhesion molecule-1 and very late antigen-4\/vascular cell adhesion molecule-1 pathways.J Exp Med 1991;173: 1297\u20131304.","journal-title":"J Exp Med"},{"key":"BF02821934_CR28","doi-asserted-by":"publisher","first-page":"574","DOI":"10.4049\/jimmunol.158.2.574","volume":"158","author":"A Kantele","year":"1997","unstructured":"Kantele Aet al. Homing potentials of circulating lymphocytes in humans depend on the site of activation.J Immunol 1997;158: 574\u2013579.","journal-title":"J Immunol"},{"key":"BF02821934_CR29","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1084\/jem.175.6.1739","volume":"175","author":"E Roldan","year":"1992","unstructured":"Roldan E, Garcia-Pardo A, Brieva JA. VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion.J Exp Med 1992;175: 1739\u20131747.","journal-title":"J Exp Med"},{"key":"BF02821934_CR30","first-page":"89","volume-title":"Adhesion molecules and chemokines in lymphocyte trafficking","author":"DD Taub","year":"1997","unstructured":"Taub DD, Murphy WJ. Chemokines as regulators of leukocyte adhesion and migration. In: Hamann A (Ed.).Adhesion molecules and chemokines in lymphocyte trafficking. Harwood Acad. Publ., The Netherlands. 1997, pp 89\u2013128."},{"key":"BF02821934_CR31","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/eji.1830270729","volume":"27","author":"M D\u2019Apuzzo","year":"1997","unstructured":"D\u2019Apuzzo Met al. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4.Eur J Immunol 1997;27: 1788\u20131793.","journal-title":"Eur J Immunol"},{"key":"BF02821934_CR32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/35876","volume":"391","author":"MD Gunn","year":"1998","unstructured":"Gunn MDet al. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt\u2019s lymphoma receptor-1.Nature 1998;391: 799\u2013803.","journal-title":"Nature"},{"key":"BF02821934_CR33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1084\/jem.150.4.792","volume":"150","author":"H Kubawaga","year":"1979","unstructured":"Kubawaga Het al. Studies on the clonal origin of multiple myeloma.J Exp Med 1979;150: 792\u2013807.","journal-title":"J Exp Med"},{"key":"BF02821934_CR34","first-page":"677","volume":"47","author":"EJEG Bast","year":"1982","unstructured":"Bast EJEG, Van Camp B, Reynaert P, Wiringa G, Ballieux RE. Idiotypic peripheral blood lymphocytes in monoclonal gammopathy.Clin Exp Immunol 1982;47: 677\u2013682.","journal-title":"Clin Exp Immunol"},{"key":"BF02821934_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2141.1989.tb07742.x","volume":"73","author":"I Van Riet","year":"1989","unstructured":"Van Riet Iet al. Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of Multiple Myeloma patients by immunoglobulin gene rearrangement studies.Brit J Haematol 1989;73: 289\u2013295.","journal-title":"Brit J Haematol"},{"key":"BF02821934_CR36","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1182\/blood.V70.5.1550.1550","volume":"70","author":"J Berenson","year":"1987","unstructured":"Berenson J, Wong R, Kim K, Brown N, Lichtenstein A. Evidence for peripheral blood B lymphocytes but not T lymphocyte involvement in multiple myeloma.Blood 1987;70: 1550\u20131553.","journal-title":"Blood"},{"key":"BF02821934_CR37","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1182\/blood.V80.9.2326.2326","volume":"80","author":"M Bakkus","year":"1992","unstructured":"Bakkus M, Heirman C, Van Riet I, Van Camp B, Thielemans K. Evidence that multiple myeloma immunoglobulin heavy chainVDJ genes contain somatic mutations but show no intraclonal variation.Blood 1992;80: 2326\u20132335.","journal-title":"Blood"},{"key":"BF02821934_CR38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1182\/blood.V85.2.436.436","volume":"85","author":"PL Bergsagel","year":"1995","unstructured":"Bergsagel PLet al. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.Blood 1995;85: 436\u2013447.","journal-title":"Blood"},{"key":"BF02821934_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/10428199609054775","volume":"22","author":"LM Pilarski","year":"1996","unstructured":"Pilarski LM, Masellis-Smith A, Szczepec A, Mant MJ, Belch AR. Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma.Leuk Lymph 1996;22: 375\u2013383.","journal-title":"Leuk Lymph"},{"key":"BF02821934_CR40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1182\/blood.V90.1.340.340_340_345","volume":"90","author":"NE Kay","year":"1997","unstructured":"Kay NEet al. Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial.Blood 1997;90: 340\u2013345.","journal-title":"Blood"},{"key":"BF02821934_CR41","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1182\/blood.V88.2.622.bloodjournal882622","volume":"88","author":"PA McSweeney","year":"1996","unstructured":"McSweeney PAet al. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.Blood 1996;88: 622\u2013632.","journal-title":"Blood"},{"key":"BF02821934_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/10428199709068274","volume":"27","author":"B Pope","year":"1997","unstructured":"Pope Bet al. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.Leuk Lymph 1997;27: 83\u201391.","journal-title":"Leuk Lymph"},{"key":"BF02821934_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-2141.1997.72653.x","volume":"97","author":"AC Rawstron","year":"1997","unstructured":"Rawstron ACet al. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.Brit J Haematol 1997;97: 46\u201355.","journal-title":"Brit J Haematol"},{"key":"BF02821934_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1046\/j.1365-2141.1997.d01-2115.x","volume":"97","author":"U Schneider","year":"1997","unstructured":"Schneider U, van Lessen A, Huhn D, Serke S. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen.Brit J Haematol 1997;97: 56\u201364.","journal-title":"Brit J Haematol"},{"key":"BF02821934_CR45","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1182\/blood.V88.5.1780.1780","volume":"88","author":"TE Witzig","year":"1996","unstructured":"Witzig TEet al. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.Blood 1996;88: 1780\u20131787.","journal-title":"Blood"},{"key":"BF02821934_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1126\/science.272.5258.60","volume":"272","author":"EC Butcher","year":"1996","unstructured":"Butcher EC, Picker LJ. Lymphocyte homing and homeostasis.Science 1996;272: 60\u201366.","journal-title":"Science"},{"key":"BF02821934_CR47","unstructured":"Vanderkerken K, Asosingh K, Braet P, Van Riet I, Van Camp B. Insulin-like growth factor-1 acts as a chemoattractant for multiple myeloma cells. (Submitted)."},{"key":"BF02821934_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood.V74.1.11.11","volume":"74","author":"XG Zhang","year":"1989","unstructured":"Zhang XG, Klein B, Bataille R. Interleukin-6 is a potent myeloma cell growth factor in patients with aggressive multiple myeloma.Blood 1989;74: 11\u201313.","journal-title":"Blood"},{"key":"BF02821934_CR49","first-page":"193","volume":"1","author":"B Klein","year":"1990","unstructured":"Klein Bet al. Interleukin-6 is the central tumor growth factorin vitro andin vivo in multiple myeloma.Eur Cytokine Net 1990;1: 193\u2013201.","journal-title":"Eur Cytokine Net"},{"key":"BF02821934_CR50","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1182\/blood.V73.2.517.517","volume":"73","author":"B Klein","year":"1989","unstructured":"Klein Bet al. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.Blood 1989;73: 517\u2013526.","journal-title":"Blood"},{"key":"BF02821934_CR51","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood.V84.7.2269.2269","volume":"84","author":"HM Lokhorst","year":"1994","unstructured":"Lokhorst HMet al. Primary tumor cells of myeloma patients induce Interleukin-6 secretion in long-term bone marrow cultures.Blood 1994;84: 2269\u20132277.","journal-title":"Blood"},{"key":"BF02821934_CR52","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1084\/jem.179.4.1337","volume":"177","author":"XG Zhang","year":"1994","unstructured":"Zhang XGet al. Ciliary neutropic factor, interleukin-11, leukemia inhibitory factor and oncostatin M are growth factors for human myeloma cell lines using the interleukin-6 signal transducer gp130.J Exp Med 1994;177: 1337\u20131342.","journal-title":"J Exp Med"},{"key":"BF02821934_CR53","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1182\/blood.V85.9.2521.bloodjournal8592521","volume":"85","author":"ZY Lu","year":"1995","unstructured":"Lu ZYet al. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.Blood 1995;85: 2521\u20132527.","journal-title":"Blood"},{"key":"BF02821934_CR54","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1365-2141.1994.tb05115.x","volume":"88","author":"RM Lemoli","year":"1994","unstructured":"Lemoli RMet al. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells.Brit J Haematol 1994;88: 760\u2013769.","journal-title":"Brit J Haematol"},{"key":"BF02821934_CR55","first-page":"4","volume":"32","author":"B Klein","year":"1995","unstructured":"Klein B. Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.Semin Hematol 1995;32: 4\u201319.","journal-title":"Semin Hematol"},{"key":"BF02821934_CR56","first-page":"335","volume":"4","author":"MY Gordon","year":"1989","unstructured":"Gordon MY, Greaves MF. Physiological mechanisms of stem cell regulation in bone marrow transplantation and haematopoiesis.Bone Marrow Transplant 1989;4: 335\u2013338.","journal-title":"Bone Marrow Transplant"},{"key":"BF02821934_CR57","first-page":"619","volume-title":"Bailli\u00e8re Tindall","author":"BR Clark","year":"1992","unstructured":"Clark BR, Gallangher JT, Dexter TM. Cell adhesion in the stromal regulation of haemopoiesis. In: Lord BI, Dexter TM (eds). Bailli\u00e8re Tindall, W.B. Saunders, London, U.K.Clinical Haematology, 1992,5: 619\u2013652."},{"key":"BF02821934_CR58","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-2141.1991.tb08050.x","volume":"79","author":"I Van Riet","year":"1991","unstructured":"Van Riet Iet al. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells.Brit J Haematol 1991;79: 421\u2013427.","journal-title":"Brit J Haematol"},{"key":"BF02821934_CR59","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.4049\/jimmunol.130.3.1132","volume":"130","author":"KC Anderson","year":"1983","unstructured":"Anderson KC, Park EK, Bates MP. Antigens on human plasma cells identified by monoclonal antibodies.J Immunol 1983;130: 1132\u20131138.","journal-title":"J Immunol"},{"key":"BF02821934_CR60","first-page":"3647","volume":"55","author":"C Pellat-Deceunynck","year":"1995","unstructured":"Pellat-Deceunynck Cet al. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumour specific spreading, and immortalization.Cancer Res 1995;55: 3647\u20133653.","journal-title":"Cancer Res"},{"key":"BF02821934_CR61","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1182\/blood.V82.12.3721.3721","volume":"82","author":"N Huang","year":"1993","unstructured":"Huang Net al. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: possible involvement of MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells.Blood 1993;82: 3721\u20133729.","journal-title":"Blood"},{"key":"BF02821934_CR62","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1182\/blood.V85.12.3704.bloodjournal85123704","volume":"85","author":"N Huang","year":"1995","unstructured":"Huang Net al. Expression of CD21 antigen on myeloma cells and its involvement in their adhesion to bone marrow stromal cells.Blood 1995;85: 3704\u20133712.","journal-title":"Blood"},{"key":"BF02821934_CR63","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood.V81.3.767.767","volume":"81","author":"RC Ridley","year":"1993","unstructured":"Ridley RCet al. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen.Blood 1993;81: 767\u2013774.","journal-title":"Blood"},{"key":"BF02821934_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2141.1992.tb08236.x","volume":"81","author":"HF Barker","year":"1992","unstructured":"Barker HF, Hamilton MS, Ball J, Drew M, Franklin IM. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells.Brit J Haematol 1992;81: 331\u2013335.","journal-title":"Brit J Haematol"},{"key":"BF02821934_CR65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1182\/blood.V76.2.377.377","volume":"76","author":"B Van Camp","year":"1990","unstructured":"Van Camp Bet al. Plasma cells in multiple myeloma express a natural killer cell associated antigen: CD56 (NKH-1; Leu 19),Blood 1990;76: 377\u2013382.","journal-title":"Blood"},{"key":"BF02821934_CR66","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood.V79.8.2068.2068","volume":"79","author":"EJM Ahsmann","year":"1992","unstructured":"Ahsmann EJM, Lokhorst HM, Dekker AW, Bloem AC. Lymphocyte function associated antigen-1 expression on plasma cell correlates with tumor growth in multiple myeloma.Blood 1992;79: 2068\u20132075.","journal-title":"Blood"},{"key":"BF02821934_CR67","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1600-0609.1996.tb01392.x","volume":"57","author":"L Faid","year":"1996","unstructured":"Faid Let al. Adhesive interactions between tumor cells and bone marrow stroma elements in human multiple myeloma.Eur J Haematol 1996;57: 349\u2013358.","journal-title":"Eur J Haematol"},{"key":"BF02821934_CR68","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/BF01738298","volume":"64","author":"IAM Denkers","year":"1992","unstructured":"Denkers IAM, Beelen RHJ, Ossenkoppele GJ, de Jong-de Boer AJM, Langenhuijsen MM. Differences of cellular composition and adhesion molecules expression in \u2018leukemic\u2019 as compared with \u2018normal\u2019 human long-term bone marrow cultures.Ann Hematol 1992;64: 210\u2013216.","journal-title":"Ann Hematol"},{"key":"BF02821934_CR69","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2141.1994.tb04907.x","volume":"87","author":"I Van Riet","year":"1994","unstructured":"Van Riet I, De Greef C, Del Favero H, Demanet C, Van Camp B. Production of fibronectin and adherence to fibronectin by human myeloma cell lines.Brit J Haematol 1994;87: 258\u2013265.","journal-title":"Brit J Haematol"},{"key":"BF02821934_CR70","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1182\/blood.V80.9.2306.2306","volume":"80","author":"H Uchiyama","year":"1992","unstructured":"Uchiyama H, Barut BA, Chauhan D, Cannistra SA, Anderson KC. Characterization of adhesion molecules on human myeloma cell lines.Blood 1992;80: 2306\u20132314.","journal-title":"Blood"},{"key":"BF02821934_CR71","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1182\/blood.V82.12.3712.3712","volume":"82","author":"H Uchiyama","year":"1993","unstructured":"Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC. Adhesion of human-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.Blood 1993;82: 3712\u20133720.","journal-title":"Blood"},{"key":"BF02821934_CR72","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2141.1991.tb08085.x","volume":"79","author":"MM Kawano","year":"1991","unstructured":"Kawano MMet al. Homotypic cell aggregations of human myeloma cells with ICAM-1 and LFA-1 molecules.Brit J Haematol 1991;79: 583\u2013588.","journal-title":"Brit J Haematol"},{"key":"BF02821934_CR73","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1298::AID-CNCR11>3.0.CO;2-X","volume":"77","author":"SM Sanal","year":"1996","unstructured":"Sanal SM, Yaylaci M, Mangold KA, Pantazis CG. Extensive extramedullary disease in myeloma.Cancer 1996;77: 1298\u20131302.","journal-title":"Cancer"},{"key":"BF02821934_CR74","first-page":"131","volume":"44","author":"BL Hannisdal","year":"1990","unstructured":"Hannisdal BL, Abrahamsen F, Kvaloy S, Langholm R. Extramedullary plasmacytomas and solitary plasma cell tumours of bone.Eur J Haematol 1990;44: 131\u2013134.","journal-title":"Eur J Haematol"},{"key":"BF02821934_CR75","first-page":"89","volume":"37","author":"A Bellhac\u00e8ne","year":"1996","unstructured":"Bellhac\u00e8ne A, Van Riet I, Antoine N, Van Camp B, Castronovo V. Expression of a bone matrix protein in myeloma cell lines.Proc Am Assoc Cancer Res 1996;37: 89.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF02821934_CR76","first-page":"758","volume":"8","author":"P Corradini","year":"1994","unstructured":"Corradini Pet al. Inactivation of tumor suppressor genes,p53 andRB1, in plasma cell dyscrasias.Leukemia 1994;8: 758\u2013767.","journal-title":"Leukemia"},{"key":"BF02821934_CR77","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1182\/blood.V81.10.2708.2708","volume":"81","author":"P Corradini","year":"1993","unstructured":"Corradini Pet al. Mutational activation ofN- andK-ras oncogenes in plasma cell dyscrasias.Blood 1993;81: 2708\u20132713.","journal-title":"Blood"},{"key":"BF02821934_CR78","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/10428199409114152","volume":"16","author":"RD Brown","year":"1994","unstructured":"Brown RD, Pope B, Luo X-F, Gibson J, Joshua D. The oncoprotein phenotype of plasma cells from patients with multiple myeloma.Leuk Lymph 1994;16: 147\u2013156.","journal-title":"Leuk Lymph"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02821934.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02821934\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02821934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02821934.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T02:15:51Z","timestamp":1702606551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02821934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["BF02821934"],"URL":"https:\/\/doi.org\/10.1007\/bf02821934","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]},"assertion":[{"value":"9 July 1998","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 1998","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 1998","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}